This paper reports a single case investigation of "Charles", a Deaf man with sign language aphasia following a left CVA. Anomia, or a deficit in sign retrieval, was a prominent feature of his aphasia, and this showed many of the well-documented characteristics of speech anomia. For example, sign retrieval was sensitive to familiarity, it could be cued, and there were both semantic and phonological errors. Like a previous case in the literature (Corina, Poizner, Bellugi, Feinberg, Dowd, & O'Grady-Batch, 1992), Charles demonstrated a striking dissociation between sign and gesture, since his gesture production was relatively intact. This dissociation was impervious to the iconicity of signs. So, Charles' sign production showed no effect of iconicity, and gesture production was superior to sign production even when the forms of the signs and gestures were similar. The implications of these findings for models of sign and gesture production are discussed.
Positron emission tomography (PET) was used to identify the brain regions activated during the 'inner signing' of sentences in subjects who were profoundly deaf and normally communicated using sign language. Although this appeared to involve the internal representation of hand and arm movements in space, it activated the left inferior frontal cortex rather than visuo-spatial areas. The activated region corresponds to that engaged during the silent articulation of sentences in hearing subjects. This suggests that 'inner signing' is mediated by similar regions to inner speech, and is consistent with neuropsychological data implicating the left hemisphere in the generation of sign language.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.